A pivotal trial of the Alzheimer’s drug donanemab leaves questions about how to prescribe it and minimize side effects.
Source:
About News from Science
The latest stories in science, brought to you by the @ScienceMagazine news team.
A pivotal trial of the Alzheimer’s drug donanemab leaves questions about how to prescribe it and minimize side effects.
Source:
The latest stories in science, brought to you by the @ScienceMagazine news team.